Products for Research Use Only
RegisterLogin

EIDD-2801

CAT: 0223-10-024Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0223-10-024Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
EIDD-2801 is an orally bioavailable prodrug of the antiviral nucleoside derivative N4-hydroxycytidine (NHC, EIDD-1931) . It is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps) . The compound interferes with the action of viral RNA polymerase. It exerts its antiviral action through introduction of copying errors during viral RNA replication. The active drug incorporates into the genome of RNA viruses, leading to an accumulation of mutations known as viral error catastrophe. The broad-spectrum antiviral agent EIDD-2801 inhibits viral RNA replication in various unrelated RNA viruses including influenza, Ebola, Venezuelan equine encephalitis virus (VEEV) and coronaviruses, including SARS-CoV, MERS-CoV and SARS-CoV-2. EIDD-2801 has the potential for COVID-19, seasonal and pandemic influenza treatment.
CAS Number
2349386-89-4
Type
Chemical
Purity
Greater than or equal to 98% (HPLC)
Shipping Conditions
Room Temp
Storage Conditions
Short Term Storage:+4C. Long Term Storage: -20C. Handling Advice: Protect from light. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.
Calculated Molecular Weight
329.3
Other Product Names
β-D-N4-Hydroxycytidine-5'-isopropyl ester; EIDD 2801
Physical Properties
Lyophilized

Related Products

CatalogName
61-993EID2 Antibody
33-385Glycophorin A Antibody [GYPA/280]

Alternative Products

CatalogName
GTR19167131-01EIDD-2801
TRC-E985795-50MGEIDD 2801
C13828-1gMolnupiravir (EIDD-2801)
TRC-E985797-10MGEIDD 2801-D7

Popular Products